ArticleCancer research and treatment2019

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.

Youjin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.